6 million up 11compared with revenue of 23

The more a wolf starves, the more a wolf hunts.Al Jefferson, Ryan Hollins, Brewer, and Flynn are all emotional leaders on the Timberwolves. If the Wolves played 100 percent for four quarters, they would be a 40-60 squad easily without Kevin Love.I look for the Timberwolves to win another game in the next two games, and continue to win around 38 percent of the games from there, until Kevin Love gets back.. Full-Year Revenue of $104 Million Exceeds $100 Million Milestone for First TimeCOLORADO SPRINGS, Colo.(Business Wire)Spectranetics Corporation (Nasdaq:SPNC) today reported preliminary revenue forthe quarter and year ended December 31, 2008. Preliminary revenue for the fourth quarter of 2008 was $26.6 million, up 11compared with revenue of $23.9 million for the fourth quarter of 2007.

Fourthquarter results in 2008 included a negative impact of $300,000 from foreigncurrency fluctuations following the issuance of our guidance in October 2008.Disposable product revenue rose 12 to $22.0 million, laser revenue increased 8to $2.3 million, and service and other revenue increased 8 to $2.3 million, allcompared with the fourth quarter of 2007. Of note, lead managementrevenue was particularly strong in the fourth quarter of 2007, reaching $6.9million, up 45 compared to the fourth quarter of 2006. Vascular interventionproduct sales include atherectomy products, which decreased 9, and supportcatheters, which increased 36, all compared to the year ago quarter. Vascularintervention product sales also include $1.4 million of sales of aspiration andthrombectomy products that were acquired from Kensey Nash Corporation on May 31,2008. The worldwide installed base of lasers increased to 850 as of December 31, 2008(672 in the United States), which included net laser placements of 25 units inthe fourth quarter of 2008, compared with 30 net placements in the fourthquarter of 2007.

Preliminary revenue for the year ended December 31, 2008 rose 26 to $104.0million, compared with $82.9 million during the year ended December 31, 2007. Geisenheimer, Chairman, President and ChiefExecutive Officer of Spectranetics. "In addition to the adverse impact offoreign currency fluctuations on fourth quarter revenue results, we receivedfeedback from certain customers regarding a focused effort to reduce hospitalinventory levels at year-end and, in some cases, customers noted a reduction inprocedure volumes during the quarter. Despite these challenges, I am pleasedwith our 26 sales growth in 2008, achieving preliminary annual revenue inexcess of $100 million for the first time in our history." Spectranetics management will provide full details regarding fourth quarter andfull year 2008 financial results in a press release to be issued later thisquarter followed by a conference call which will be made available to interestedparties. About SpectraneticsFounded in 1984, Spectranetics manufactures and sells the only excimer laserapproved in the United States, Europe and Japan for use in minimally invasivecardiovascular procedures. This technology treats complex cardiovascularconditions by photo-ablating multiple lesion types into tiny particles that areeasily absorbed into the blood stream. Such statements are based on current assumptions thatinvolve risks and uncertainties that could cause actual outcomes and results todiffer materially.

These risks and uncertainties may include adverse results ofthe FDA and Immigration and Customs Enforcement investigation, adverse resultsof the SEC investigation or any securities litigation in which the Company orany of its officers or directors is a party, market acceptance of excimer laseratherectomy technology, increasing price and product competition, increasedpressure on expense levels resulting from expanded sales, marketing, productdevelopment and clinical activities, uncertain success of the Company'sstrategic direction, dependence on new product development, intellectualproperty claims of third parties, availability of inventory from suppliers, thereceipt of FDA approval to market new products or applications and thetimeliness of any approvals, market acceptance of new products or applications,product defects, ability to manufacture sufficient volumes to fulfill customerdemand, availability of vendor-sourced components at reasonable prices,unexpected delays or costs associated with the Companys relocation andconsolidation of its headquarters and manufacturing operations, and pricevolatility due to the initiation or cessation of coverage, or changes inratings, by securities analysts. For a further list and description of suchrisks and uncertainties that could cause the actual results, performance orachievements of the Company to be materially different from any anticipatedresults, performance or achievements, please see the Company's previously filedSEC reports. COMPANY CONTACTS:Spectranetics CorporationGuy Childs, Chief Financial Officer(719) 633-8333orINVESTOR CONTACTS:Lippert/Heilshorn & Associates, Inc.Don Markley or Bruce Voss(310) orMEDIA CONTACTS:Joele Frank, Wilkinson Brimmer KatcherEric Brielmann/Matt Cuneo(212) 355-4449 Copyright Business Wire 2009. All is quiet on the northern front in Chicago baseball so far this winter.Which is odd, because Jim Hendry's last few winters have been highlighted by more big game hunting than a weekend with Ted Nugent.When a guy's resume includes bringing in names like Alfonso Soriano, Ted Lilly, Kosuke Fukudome and Milton Bradley, and when you consider how public Hendry's courtship of each player was, the fact that there hasn't been much of a peep from Hendry so far in November is intriguing to say the least.Yes, he traded Aaron Heilman to Arizona. And yes, he signed John Grabow to a two-year extension.But next to throwing around the salaries he's given Bradley, Fukudome and Soriano, these moves amount to about the same impact as breaking wind under water.There have been reports that the Blue Jays contacted the Cubs to gauge interest in Roy Halladay.Silence.There have been rumors that Bradley's going to be traded to New York, Tampa, Texas, Japan and an asylum.Silence.Ted Lilly had surgery on his pitching shoulder. He might not be ready until May.Silence.Are the Cubs going to replace Van Halen's "Jump" with some Simon and Garfunkel tune when they take the field in 2010While Kenny Williams is adding AARP card candidates Omar Vizquel and Andruw Jones on the South Side of town, Hendry has been noticeably absent, which means one of two things: either his new "daddy," Tom Ricketts, took away his credit card, or something's brewing.How, who, and where something goes down will likely develop in the coming weeks as the annual Winter Meetings take place.